Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
1.940
-0.110 (-5.37%)
At close: Apr 6, 2026, 4:00 PM EDT
1.989
+0.049 (2.54%)
After-hours: Apr 6, 2026, 7:58 PM EDT
Lipocine Market Cap
Lipocine has a market cap or net worth of $14.16 million as of April 6, 2026. Its market cap has decreased by -28.11% in one year.
Market Cap
14.16M
Enterprise Value
483.56K
1-Year Change
-28.11%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $14.16M, a decrease of -82.79%. That is a compound annual growth rate of -13.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 15.00M | -66.37% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 16.64M |
| Vyome Holdings | 14.95M |
| Phio Pharmaceuticals | 14.87M |
| Intensity Therapeutics | 14.48M |
| GT Biopharma | 14.18M |
| IN8bio | 14.18M |
| Biodexa Pharmaceuticals | 14.15M |
| OSR Holdings | 14.11M |